SE8704272L - Pharmaceutisk komposition - Google Patents

Pharmaceutisk komposition

Info

Publication number
SE8704272L
SE8704272L SE8704272A SE8704272A SE8704272L SE 8704272 L SE8704272 L SE 8704272L SE 8704272 A SE8704272 A SE 8704272A SE 8704272 A SE8704272 A SE 8704272A SE 8704272 L SE8704272 L SE 8704272L
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
dithia
azaspiro
alanyl
phenylpropyl
Prior art date
Application number
SE8704272A
Other languages
English (en)
Other versions
SE8704272D0 (sv
Inventor
H Siegl
R P Hof
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868626217A external-priority patent/GB8626217D0/en
Priority claimed from GB878713349A external-priority patent/GB8713349D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8704272D0 publication Critical patent/SE8704272D0/sv
Publication of SE8704272L publication Critical patent/SE8704272L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8704272A 1986-11-03 1987-11-02 Pharmaceutisk komposition SE8704272L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868626217A GB8626217D0 (en) 1986-11-03 1986-11-03 Pharmaceutical compositions
GB878713349A GB8713349D0 (en) 1987-06-08 1987-06-08 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
SE8704272D0 SE8704272D0 (sv) 1987-11-02
SE8704272L true SE8704272L (sv) 1988-05-04

Family

ID=26291485

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8704272A SE8704272L (sv) 1986-11-03 1987-11-02 Pharmaceutisk komposition

Country Status (25)

Country Link
KR (1) KR960005145B1 (sv)
AT (1) AT397343B (sv)
AU (1) AU615883B2 (sv)
BE (1) BE1002063A4 (sv)
CA (1) CA1314222C (sv)
CH (1) CH677189A5 (sv)
DE (1) DE3736505A1 (sv)
DK (1) DK574087A (sv)
ES (1) ES2010524A6 (sv)
FI (1) FI874823A (sv)
FR (1) FR2605885B1 (sv)
GR (1) GR871680B (sv)
HK (1) HK138893A (sv)
HU (1) HU199681B (sv)
IE (1) IE60496B1 (sv)
IL (1) IL84343A (sv)
IT (1) IT1212037B (sv)
LU (1) LU87034A1 (sv)
MY (1) MY102124A (sv)
NL (1) NL8702502A (sv)
NO (1) NO874539L (sv)
NZ (1) NZ222401A (sv)
PH (1) PH23249A (sv)
PT (1) PT86062B (sv)
SE (1) SE8704272L (sv)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3818245A1 (de) * 1988-05-28 1989-12-07 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln
FR2733911B1 (fr) * 1995-05-09 1998-05-29 Takeda Chemical Industries Ltd Composition pharmaceutique pour maladies renales ou cardio-vasculaires

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) * 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4520021A (en) * 1982-07-02 1985-05-28 Merck & Co., Inc. Substituted caprolactam derivatives as antihypertensives
DE3437917A1 (de) * 1984-10-17 1986-04-17 Bayer Ag, 5090 Leverkusen Kombination von dihydropyridinen mit ace-hemmern sowie ihre verwendung in arzneimitteln
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
GB2198641B (en) * 1986-11-03 1990-09-19 Sandoz Ltd Pharmaceutical composition for use against hypertension and congestive heart failure
IL88502A (en) * 1987-12-14 1993-04-04 Squibb & Sons Inc Pharmaceutical compositions containing an angiotensin converting enzyme inhibitor

Also Published As

Publication number Publication date
AU8057687A (en) 1988-05-05
PT86062B (pt) 1990-11-07
ES2010524A6 (es) 1989-11-16
NO874539L (no) 1988-05-04
HUT47847A (en) 1989-04-28
IT8748553A0 (it) 1987-10-30
BE1002063A4 (fr) 1990-06-12
DE3736505A1 (de) 1988-05-05
KR880006197A (ko) 1988-07-22
ATA286987A (de) 1993-08-15
IE872951L (en) 1988-05-03
DK574087A (da) 1988-05-04
NZ222401A (en) 1991-04-26
CA1314222C (en) 1993-03-09
KR960005145B1 (ko) 1996-04-22
AT397343B (de) 1994-03-25
PT86062A (en) 1987-12-01
HK138893A (en) 1993-12-24
IL84343A0 (en) 1990-02-09
IT1212037B (it) 1989-11-08
FI874823A0 (fi) 1987-11-02
FI874823A (fi) 1988-05-04
IE60496B1 (en) 1994-07-27
AU615883B2 (en) 1991-10-17
NL8702502A (nl) 1988-06-01
IL84343A (en) 1993-07-08
HU199681B (en) 1990-03-28
LU87034A1 (fr) 1988-05-03
NO874539D0 (no) 1987-11-02
FR2605885B1 (fr) 1993-09-10
FR2605885A1 (fr) 1988-05-06
PH23249A (en) 1989-06-16
CH677189A5 (sv) 1991-04-30
DK574087D0 (da) 1987-11-02
GR871680B (en) 1988-05-02
MY102124A (en) 1992-03-31
SE8704272D0 (sv) 1987-11-02

Similar Documents

Publication Publication Date Title
HU905605D0 (en) Substituted imidazoles
BG103143A (en) Substituted pyrido- or pirimidocontaining 6,6- or 6,7-bicyclic derivatives
NO900264D0 (no) Fremgangsmaate for fremstilling av en kombinasjon av beta-blokkerende/angiotensin ii-blokkerende antihypertensive midler.
DE3868910D1 (de) Implantat zur befestigung von zahnprothesen.
DK245883D0 (da) Fremgangsmade til fremstilling af en eller flere af de rene enkeltfaktorer 1,2,3,4 og 5 af teichomycin a2 eller farmaceutisk acceptable salte deraf
IT1187643B (it) 1-(idrossometil)-1,6,7,11b-tetraidro-2h-(1,3)ossazino-oppure-tiazino(4,3-a)isochinolin-de rivati,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
ATE88349T1 (de) Hyperimmunizierte milch gegen bluthochdruck.
DE3571438D1 (en) Substituted hexahydro arylquinolizines
SE8704272L (sv) Pharmaceutisk komposition
GR862285B (en) Pharmaceutical compositions for treating the high blood pressure
BG103859A (en) The use of 1-ar(alk)yl-imidazolin-2-on for the treatment of fear and stress conditions
DK74184A (da) Anti-angina-middel
IT8620828A0 (it) Procedimento per la produzione di una l-aspartil-l-fenilalanina n-protetta.
DK541789A (da) Farmaceutisk praeparat indeholdende 5-t-butyl-3-oen-(1-(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanylaa-2,3-dihydro-1,3,4-thiadiazol-2-(s)-carboxylsyre eller derivater deraf, og fremgangsmaade til dets fremstilling
FI893211A (fi) Antihypertensiva, n-terminala eteraminodiolamino-syraderivat.
GB9014705D0 (en) Pharmaceutical composition for use against hypertension and congestive heart failure
DE68905343T2 (de) Dosisform zur verabreichung von calciumantagonisten.
DK153473C (da) (1-phenethyl)-alfa-phenyl-piperidin-3-propannitril-derivater samt laegemiddel anvendeligt som calcium-antagonist og som antihypertensionsmiddel
IT8619931A0 (it) Procedimento per la preparazione della 1-(n-metilamidino)-3-(2,6-dimetilfe nil) urea e dei suoi sali farmaceuticamente accettabili.
IT8448425A0 (it) Ga di titanio, saldabili in bocca corone e ponti odontoiatrici in le-